側弯症管理の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

世界の側弯症管理の市場規模は、2025年に33億米ドルになるとみられ、2025年～2032年の予測期間に3.6%のCAGRで拡大し、2032年には42億米ドルに達すると予測されています。

側弯症管理には、側弯症として知られる背骨の異常な湾曲を治療するための装具、理学療法、外科的処置などの様々な治療オプションが含まれます。側弯症管理市場は、病院、クリニック、リハビリテーションセンターなどのヘルスケア環境を対象としています。また、3Dイメージングシステムや低侵襲手術などの先端技術の採用が増加しており、治療結果や患者の回復が改善されています。市場成長の原動力は、側弯症の罹患率の増加、治療オプションの進歩、ヘルスケア支出の増加であり、より良い患者ケアと疾患管理に寄与しています。

世界の側弯症管理市場は、特に青少年や高齢化社会における側弯症の有病率の上昇など、いくつかの重要な要因によって推進されています。側弯症に対する認識の高まりと早期診断技術により、治療成績が著しく向上し、合併症が減少しました。さらに、3D画像やロボット支援手術などの技術的進歩が、治療の精度と患者の安全性を高めています。装具や理学療法のような非侵襲的治療の採用は、さらに市場の成長に寄与しています。さらに、ヘルスケア支出の増加や側弯症治療を促進する政府の取り組みが、市場拡大の原動力となっています。

側弯症管理市場は、装着型装具や3D脊髄画像システムなどの新技術の導入により、大きな機会をもたらしています。これらの技術革新は、患者にとって快適性の向上、治療結果の改善、利便性の向上をもたらします。さらに、側弯症の予防と早期発見に対する意識の拡大、ヘルスケアへのアクセスの改善が、市場の需要を促進すると予想されます。新興市場、特にアジア太平洋とラテンアメリカは、ヘルスケア投資の増加と医療インフラの改善により、未開拓の成長機会をもたらしています。共同研究、費用対効果の高いソリューションの研究開発は、市場成長をさらに加速させるとみられています。

当レポートでは、世界の側弯症管理市場について調査し、製品タイプ別、年齢層別、流通チャネル別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

第3章 側弯症管理市場機会分析

第4章 世界経済の見通し

第5章 市場背景

• 市場力学
• 規制シナリオ

第6章 主な内容

第7章 北米の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）

第8章 ラテンアメリカの側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）

第9章 西欧の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）

第10章 東欧の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）

第11章 中国を除くアジア太平洋地域の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）

第12章 中国の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）

第13章 中東・アフリカの側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）

第14章 予測要因：関連性と影響

第15章 予測の前提条件

第16章 競合分析

• 競合ダッシュボード
• 企業の詳細
  • Aspen Medical Products
  • DJO Global
  • Ottobock
  • Horton's Orthotics & Prosthetics
  • Boston O&P
  • TRULIFE.
  • Bauerfeind AG
  • Spinal Technology Inc.
  • Fited
  • Wellinks, Inc.

第17章 世界の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）、地域別

第18章 世界の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）、製品タイプ別

第19章 世界の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）、年齢層別

第20章 世界の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）、流通チャネル別

第21章 世界の側弯症管理市場分析（2019年～2024年）および予測（2025年～2032年）

第22章 使用される仮定と頭字語

第23章 調査手法

Persistence Market Research has recently released a comprehensive report on the worldwide market for scoliosis management. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global scoliosis management market from 2025 to 2032.

Key Insights:

• Scoliosis Management Market Size (2025E): USD 3.3 Billion
• Projected Market Value (2032F): USD 4.2 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 3.6%

Scoliosis Management Market - Report Scope:

Scoliosis management includes various treatment options, such as bracing, physical therapy, and surgical procedures to treat the abnormal curvature of the spine known as scoliosis. The scoliosis management market serves healthcare settings such as hospitals, clinics, and rehabilitation centers. The market is also witnessing the growing adoption of advanced technologies, such as 3D imaging systems and minimally invasive surgery, improving treatment outcomes and patient recovery. Market growth is driven by an increasing incidence of scoliosis, advancements in treatment options, and rising healthcare expenditures, contributing to better patient care and management of the condition.

Market Growth Drivers:

The global scoliosis management market is propelled by several key factors, including the rising prevalence of scoliosis, particularly among adolescents and the aging population. The growing awareness of scoliosis and early diagnosis techniques has significantly improved treatment outcomes and reduced complications. Additionally, technological advancements, such as 3D imaging and robotic-assisted surgeries, are enhancing treatment precision and patient safety. The adoption of non-invasive treatments like bracing and physical therapy is further contributing to the market's growth. Furthermore, increasing healthcare spending and government initiatives to promote scoliosis care are driving market expansion.

Market Restraints:

Despite the positive growth prospects, the scoliosis management market faces challenges such as high treatment costs, particularly for surgical procedures and advanced technologies, which may restrict market growth in developing regions. Additionally, the lack of adequate healthcare infrastructure in some regions may hinder access to effective scoliosis management solutions. Regulatory challenges, including the approval processes for new medical devices and therapies, also pose obstacles to market penetration. Addressing these barriers requires collaboration between healthcare providers, manufacturers, and policymakers to improve access to scoliosis treatments.

Market Opportunities:

The scoliosis management market presents significant opportunities driven by the introduction of new technologies, such as wearable braces and 3D spinal imaging systems. These innovations offer enhanced comfort, better treatment outcomes, and greater convenience for patients. Additionally, expanding awareness of scoliosis prevention and early detection, along with improved access to healthcare, is expected to drive market demand. Emerging markets, particularly in Asia Pacific and Latin America, present untapped growth opportunities due to increasing healthcare investments and improving medical infrastructure. Collaborations, research, and development of cost-effective solutions will further accelerate market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the scoliosis management market globally?
• Which treatment options and technologies are driving the adoption of scoliosis management solutions across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the scoliosis management market?
• Who are the key players contributing to the scoliosis management market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global scoliosis management market?

Competitive Intelligence and Business Strategy:

Leading players in the global scoliosis management market, including Medtronic, Zimmer Biomet, and Stryker Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced scoliosis treatment devices, including 3D imaging systems, minimally invasive surgical tools, and personalized braces. Collaborations with healthcare providers, academic institutions, and regulatory agencies help enhance product development and facilitate market adoption. Moreover, educating patients and healthcare professionals about new treatment options and technologies fosters market growth and enhances patient outcomes.

Key Companies Profiled:

• Medtronic
• Zimmer Biomet
• Stryker Corporation
• DePuy Synthes (Johnson & Johnson)
• NuVasive, Inc.
• SpineArt S.A.
• Orthofix Medical Inc.
• Boston Scientific Corporation
• Globus Medical, Inc.
• ATEC Spine, Inc.

Scoliosis Market Segmentation

Product type

• Cervical Thoracic Lumbar
• Thoracolumbosacral orthosis
• Lumbosacral Orthosis

Age group

• Infantile Scoliosis
• Juvenile Scoliosis
• Adolescent Scoliosis

Distribution channel

• Hospital Pharmacies
• Retail Pharmacies
• Online sales

Regions covered

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding China (APEC)
• China
• Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Taxonomy
• 2.2. Market Definition
• 2.3. Product Definition

3. Scoliosis Management Market Opportunity Analysis

• 3.1. Macro-Economic Factors
• 3.2. Opportunity Analysis

4. Global Economic Outlook

• 4.1. Global Gross Domestic Product by Region & Country

5. Market Background

• 5.1. Market Dynamics
  • 5.1.1. Drivers
  • 5.1.2. Restraints
  • 5.1.3. Opportunities
  • 5.1.4. Trends
• 5.2. Regulatory Scenario

6. Key Inclusions

• 6.1. Reimbursement Guide for Scoliosis braces
• 6.2. Pricing Analysis

7. North America Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032

• 7.1. Introduction
• 7.2. Regional Market Trends
• 7.3. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2024
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 7.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019 - 2024
  • 7.5.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  • 7.5.2. Thoracolumbosacral Orthosis (TLSO)
  • 7.5.3. Lumbosacral Orthosis (LSO)
• 7.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
• 7.7. Historical Market Size (US$ Bn) Trend Analysis By Age Group, 2019 - 2024
  • 7.7.1. Infantile Scoliosis
  • 7.7.2. Juvenile Scoliosis
  • 7.7.3. Adolescent Scoliosis
• 7.8. Market Size (US$ Bn) Forecast By Age Group, 2025 - 2032
• 7.9. Historical Market Size (US$ Bn) Trend Analysis By Distribution Channel, 2019 - 2024
  • 7.9.1. Hospital Pharmacies
  • 7.9.2. Retail Pharmacies
  • 7.9.3. Online sales
• 7.10. Market Size (US$ Bn) Forecast By Distribution Channel, 2025 - 2032
• 7.11. Drivers and Restraints: Impact Analysis
• 7.12. Market Attractiveness Analysis
  • 7.12.1. By Country
  • 7.12.2. By Product Type
  • 7.12.3. By Age Group
  • 7.12.4. By Distribution Channel
• 7.13. Key Market Participants - Intensity Mapping
• 7.14. Key Mergers & Acquisitions

8. Latin America Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032

• 8.1. Introduction
• 8.2. Regional Market Trends
• 8.3. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2024
  • 8.3.1. Brazil
  • 8.3.2. Mexico
  • 8.3.3. Rest of Latin America
• 8.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 8.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019 - 2024
  • 8.5.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  • 8.5.2. Thoracolumbosacral Orthosis (TLSO)
  • 8.5.3. Lumbosacral Orthosis (LSO)
• 8.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
• 8.7. Historical Market Size (US$ Bn) Trend Analysis By Age Group, 2019 - 2024
  • 8.7.1. Infantile Scoliosis
  • 8.7.2. Juvenile Scoliosis
  • 8.7.3. Adolescent Scoliosis
• 8.8. Market Size (US$ Bn) Forecast By Age Group, 2025 - 2032
• 8.9. Historical Market Size (US$ Bn) Trend Analysis By Distribution Channel, 2019 - 2024
  • 8.9.1. Hospital Pharmacies
  • 8.9.2. Retail Pharmacies
  • 8.9.3. Online sales
• 8.10. Market Size (US$ Bn) Forecast By Distribution Channel, 2025 - 2032
• 8.11. Drivers and Restraints: Impact Analysis
• 8.12. Market Attractiveness Analysis
  • 8.12.1. By Country
  • 8.12.2. By Product Type
  • 8.12.3. By Age Group
  • 8.12.4. By Distribution Channel
• 8.13. Key Market Participants - Intensity Mapping
• 8.14. Key Mergers & Acquisitions

9. Western Europe Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032

• 9.1. Introduction
• 9.2. Regional Market Trends
• 9.3. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2024
  • 9.3.1. Germany
  • 9.3.2. U.K
  • 9.3.3. France
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Western Europe
• 9.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 9.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019 - 2024
  • 9.5.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  • 9.5.2. Thoracolumbosacral Orthosis (TLSO)
  • 9.5.3. Lumbosacral Orthosis (LSO)
• 9.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
• 9.7. Historical Market Size (US$ Bn) Trend Analysis By Age Group, 2019 - 2024
  • 9.7.1. Infantile Scoliosis
  • 9.7.2. Juvenile Scoliosis
  • 9.7.3. Adolescent Scoliosis
• 9.8. Market Size (US$ Bn) Forecast By Age Group, 2025 - 2032
• 9.9. Historical Market Size (US$ Bn) Trend Analysis By Distribution Channel, 2019 - 2024
  • 9.9.1. Hospital Pharmacies
  • 9.9.2. Retail Pharmacies
  • 9.9.3. Online sales
• 9.10. Market Size (US$ Bn) Forecast By Distribution Channel, 2025 - 2032
• 9.11. Drivers and Restraints: Impact Analysis
• 9.12. Market Attractiveness Analysis
  • 9.12.1. By Country
  • 9.12.2. By Product Type
  • 9.12.3. By Age Group
  • 9.12.4. By Distribution Channel
• 9.13. Key Market Participants - Intensity Mapping
• 9.14. Key Mergers & Acquisitions

10. Eastern Europe Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032

• 10.1. Introduction
• 10.2. Regional Market Trends
• 10.3. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2024
  • 10.3.1. Russia
  • 10.3.2. Poland
  • 10.3.3. Rest of Eastern Europe
• 10.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 10.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019 - 2024
  • 10.5.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  • 10.5.2. Thoracolumbosacral Orthosis (TLSO)
  • 10.5.3. Lumbosacral Orthosis (LSO)
• 10.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
• 10.7. Historical Market Size (US$ Bn) Trend Analysis By Age Group, 2019 - 2024
  • 10.7.1. Infantile Scoliosis
  • 10.7.2. Juvenile Scoliosis
  • 10.7.3. Adolescent Scoliosis
• 10.8. Market Size (US$ Bn) Forecast By Age Group, 2025 - 2032
• 10.9. Historical Market Size (US$ Bn) Trend Analysis By Distribution Channel, 2019 - 2024
  • 10.9.1. Hospital Pharmacies
  • 10.9.2. Retail Pharmacies
  • 10.9.3. Online sales
• 10.10. Market Size (US$ Bn) Forecast By Distribution Channel, 2025 - 2032
• 10.11. Drivers and Restraints: Impact Analysis
• 10.12. Market Attractiveness Analysis
  • 10.12.1. By Country
  • 10.12.2. By Product Type
  • 10.12.3. By Age Group
  • 10.12.4. By Distribution Channel
• 10.13. Key Market Participants - Intensity Mapping
• 10.14. Key Mergers & Acquisitions

11. Asia Pacific Excluding China Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032

• 11.1. Introduction
• 11.2. Regional Market Trends
• 11.3. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2024
  • 11.3.1. India
  • 11.3.2. Australia and New Zealand
  • 11.3.3. ASEAN
  • 11.3.4. Rest of APECJ
• 11.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 11.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019 - 2024
  • 11.5.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  • 11.5.2. Thoracolumbosacral Orthosis (TLSO)
  • 11.5.3. Lumbosacral Orthosis (LSO)
• 11.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
• 11.7. Historical Market Size (US$ Bn) Trend Analysis By Age Group, 2019 - 2024
  • 11.7.1. Infantile Scoliosis
  • 11.7.2. Juvenile Scoliosis
  • 11.7.3. Adolescent Scoliosis
• 11.8. Market Size (US$ Bn) Forecast By Age Group, 2025 - 2032
• 11.9. Historical Market Size (US$ Bn) Trend Analysis By Distribution Channel, 2019 - 2024
  • 11.9.1. Hospital Pharmacies
  • 11.9.2. Retail Pharmacies
  • 11.9.3. Online sales
• 11.10. Market Size (US$ Bn) Forecast By Distribution Channel, 2025 - 2032
• 11.11. Drivers and Restraints: Impact Analysis
• 11.12. Market Attractiveness Analysis
  • 11.12.1. By Country
  • 11.12.2. By Product Type
  • 11.12.3. By Age Group
  • 11.12.4. By Distribution Channel
• 11.13. Key Market Participants - Intensity Mapping
• 11.14. Key Mergers & Acquisitions

12. China Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032

• 12.1. Introduction
• 12.2. Regional Market Trends
• 12.3. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019 - 2024
  • 12.3.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  • 12.3.2. Thoracolumbosacral Orthosis (TLSO)
  • 12.3.3. Lumbosacral Orthosis (LSO)
• 12.4. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
• 12.5. Historical Market Size (US$ Bn) Trend Analysis By Age Group, 2019 - 2024
  • 12.5.1. Infantile Scoliosis
  • 12.5.2. Juvenile Scoliosis
  • 12.5.3. Adolescent Scoliosis
• 12.6. Market Size (US$ Bn) Forecast By Age Group, 2025 - 2032
• 12.7. Historical Market Size (US$ Bn) Trend Analysis By Distribution Channel, 2019 - 2024
  • 12.7.1. Hospital Pharmacies
  • 12.7.2. Retail Pharmacies
  • 12.7.3. Online sales
• 12.8. Market Size (US$ Bn) Forecast By Distribution Channel, 2025 - 2032
• 12.9. Drivers and Restraints: Impact Analysis
• 12.10. Market Attractiveness Analysis
  • 12.10.1. By Product Type
  • 12.10.2. By Age Group
  • 12.10.3. By Distribution Channel
• 12.11. Key Market Participants - Intensity Mapping
• 12.12. Key Mergers & Acquisitions

13. Middle East and Africa Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032

• 13.1. Introduction
• 13.2. Regional Market Trends
• 13.3. Historical Market Size (US$ Bn) Analysis By Country, 2019 - 2024
  • 13.3.1. GCC Countries
  • 13.3.2. South Africa
  • 13.3.3. Rest of Middle East and Africa
• 13.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
• 13.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019 - 2024
  • 13.5.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  • 13.5.2. Thoracolumbosacral Orthosis (TLSO)
  • 13.5.3. Lumbosacral Orthosis (LSO)
• 13.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
• 13.7. Historical Market Size (US$ Bn) Trend Analysis By Age Group, 2019 - 2024
  • 13.7.1. Infantile Scoliosis
  • 13.7.2. Juvenile Scoliosis
  • 13.7.3. Adolescent Scoliosis
• 13.8. Market Size (US$ Bn) Forecast By Age Group, 2025 - 2032
• 13.9. Historical Market Size (US$ Bn) Trend Analysis By Distribution Channel, 2019 - 2024
  • 13.9.1. Hospital Pharmacies
  • 13.9.2. Retail Pharmacies
  • 13.9.3. Online sales
• 13.10. Market Size (US$ Bn) Forecast By Distribution Channel, 2025 - 2032
• 13.11. Drivers and Restraints: Impact Analysis
• 13.12. Market Attractiveness Analysis
  • 13.12.1. By Country
  • 13.12.2. By Product Type
  • 13.12.3. By Age Group
  • 13.12.4. By Distribution Channel
• 13.13. Key Market Participants - Intensity Mapping
• 13.14. Key Mergers & Acquisitions

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Competition Analysis

• 16.1.Competition Dashboard
• 16.2.Company Deep Dive
  • 16.2.1. Aspen Medical Products
    • 16.2.1.1. Overview
    • 16.2.1.2. Product and Age Group Portfolio
    • 16.2.1.3. Production Footprint
    • 16.2.1.4. Sales Footprint
    • 16.2.1.5. Channel Footprint
    • 16.2.1.6. Strategy
      • 16.2.1.6.1. Marketing Strategy
      • 16.2.1.6.2. Product Strategy
      • 16.2.1.6.3. Channel Strategy
  • 16.2.2. DJO Global
    • 16.2.2.1. Overview
    • 16.2.2.2. Product and Age Group Portfolio
    • 16.2.2.3. Production Footprint
    • 16.2.2.4. Sales Footprint
    • 16.2.2.5. Channel Footprint
    • 16.2.2.6. Strategy
      • 16.2.2.6.1. Marketing Strategy
      • 16.2.2.6.2. Product Strategy
      • 16.2.2.6.3. Channel Strategy
  • 16.2.3. Ottobock
    • 16.2.3.1. Overview
    • 16.2.3.2. Product and Age Group Portfolio
    • 16.2.3.3. Production Footprint
    • 16.2.3.4. Sales Footprint
    • 16.2.3.5. Channel Footprint
    • 16.2.3.6. Strategy
      • 16.2.3.6.1. Marketing Strategy
      • 16.2.3.6.2. Product Strategy
      • 16.2.3.6.3. Channel Strategy
  • 16.2.4. Horton's Orthotics & Prosthetics
    • 16.2.4.1. Overview
    • 16.2.4.2. Product and Age Group Portfolio
    • 16.2.4.3. Production Footprint
    • 16.2.4.4. Sales Footprint
    • 16.2.4.5. Channel Footprint
    • 16.2.4.6. Strategy
      • 16.2.4.6.1. Marketing Strategy
      • 16.2.4.6.2. Product Strategy
      • 16.2.4.6.3. Channel Strategy
  • 16.2.5. Boston O&P
    • 16.2.5.1. Overview
    • 16.2.5.2. Product and Age Group Portfolio
    • 16.2.5.3. Production Footprint
    • 16.2.5.4. Sales Footprint
    • 16.2.5.5. Channel Footprint
    • 16.2.5.6. Strategy
      • 16.2.5.6.1. Marketing Strategy
      • 16.2.5.6.2. Product Strategy
      • 16.2.5.6.3. Channel Strategy
  • 16.2.6. TRULIFE.
    • 16.2.6.1. Overview
    • 16.2.6.2. Product and Age Group Portfolio
    • 16.2.6.3. Production Footprint
    • 16.2.6.4. Sales Footprint
    • 16.2.6.5. Channel Footprint
    • 16.2.6.6. Strategy
      • 16.2.6.6.1. Marketing Strategy
      • 16.2.6.6.2. Product Strategy
      • 16.2.6.6.3. Channel Strategy
  • 16.2.7. Bauerfeind AG
    • 16.2.7.1. Overview
    • 16.2.7.2. Product and Age Group Portfolio
    • 16.2.7.3. Production Footprint
    • 16.2.7.4. Sales Footprint
    • 16.2.7.5. Channel Footprint
    • 16.2.7.6. Strategy
      • 16.2.7.6.1. Marketing Strategy
      • 16.2.7.6.2. Product Strategy
      • 16.2.7.6.3. Channel Strategy
  • 16.2.8. Spinal Technology Inc.
    • 16.2.8.1. Overview
    • 16.2.8.2. Product and Age Group Portfolio
    • 16.2.8.3. Production Footprint
    • 16.2.8.4. Sales Footprint
    • 16.2.8.5. Channel Footprint
    • 16.2.8.6. Strategy
      • 16.2.8.6.1. Marketing Strategy
      • 16.2.8.6.2. Product Strategy
      • 16.2.8.6.3. Channel Strategy
  • 16.2.9. Fited
    • 16.2.9.1. Overview
    • 16.2.9.2. Product and Age Group Portfolio
    • 16.2.9.3. Production Footprint
    • 16.2.9.4. Sales Footprint
    • 16.2.9.5. Channel Footprint
    • 16.2.9.6. Strategy
      • 16.2.9.6.1. Marketing Strategy
      • 16.2.9.6.2. Product Strategy
      • 16.2.9.6.3. Channel Strategy
  • 16.2.10. Wellinks, Inc.
    • 16.2.10.1. Overview
    • 16.2.10.2. Product and Age Group Portfolio
    • 16.2.10.3. Production Footprint
    • 16.2.10.4. Sales Footprint
    • 16.2.10.5. Channel Footprint
    • 16.2.10.6. Strategy
      • 16.2.10.6.1. Marketing Strategy
      • 16.2.10.6.2. Product Strategy
      • 16.2.10.6.3. Channel Strategy

17. Global Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032 By Region

• 17.1.Introduction / Key Findings
• 17.2.Historical Market Size (US$ Bn) Analysis By Region
  • 17.2.1. North America
  • 17.2.2. Latin America
  • 17.2.3. Western Europe
  • 17.2.4. Eastern Europe
  • 17.2.5. Asia Pacific Excluding China
  • 17.2.6. China
  • 17.2.7. Middle East and Africa
• 17.3. Market Size (US$ Bn) Forecast By Region
• 17.4. Market Attractiveness Analysis By Region

18. Global Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Product Type

• 18.1. Introduction/Key Finding
• 18.2. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2019 - 2024
  • 18.2.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  • 18.2.2. Thoracolumbosacral Orthosis (TLSO)
  • 18.2.3. Lumbosacral Orthosis (LSO)
• 18.3. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
• 18.4. Market Attractiveness Analysis By Product Type

19. Global Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Age Group

• 19.1. Introduction/Key Finding
• 19.2. Historical Market Size (US$ Bn) Trend Analysis By Age Group, 2019 - 2024
  • 19.2.1. Infantile Scoliosis
  • 19.2.2. Juvenile Scoliosis
  • 19.2.3. Adolescent Scoliosis
• 19.3. Market Size (US$ Bn) Forecast By Age Group, 2025 - 2032
• 19.4. Market Attractiveness Analysis By Age Group

20. Global Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Distribution Channel

• 20.1. Introduction/Key Finding
• 20.2. Historical Market Size (US$ Bn) Trend Analysis By Distribution Channel, 2019 - 2024
  • 20.2.1. Hospital Pharmacies
  • 20.2.2. Retail Pharmacies
  • 20.2.3. Online sales
• 20.3. Market Size (US$ Bn) Forecast By Distribution Channel, 2025 - 2032
• 20.4. Market Attractiveness Analysis By Distribution Channel

21. Global Scoliosis Management Market Analysis 2019 - 2024 and Forecast 2025 - 2032

• 21.1. Y-o-Y Growth Analysis By All Segment
• 21.2. Absolute $ Opportunity

22. Assumptions and Acronyms Used

23. Research Methodology